Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Allow: / SITEMAP: |
Title | Avadel Pharmaceuticals – Transforming Treatment Options for |
Description | Transforming medicines to transform Avadel pharmaceuticals is transforming medicines to address the problems patients and healthcare professionals face with current treatment options for |
Keywords | N/A |
WebSite | avadel.com |
Host IP | 99.84.216.101 |
Location | United States |
Site | Rank |
US$26,816,275
Last updated: 2023-05-07 08:33:45
avadel.com has Semrush global rank of 394,697. avadel.com has an estimated worth of US$ 26,816,275, based on its estimated Ads revenue. avadel.com receives approximately 3,094,186 unique visitors each day. Its web server is located in United States, with IP address 99.84.216.101. According to SiteAdvisor, avadel.com is safe to visit. |
Purchase/Sale Value | US$26,816,275 |
Daily Ads Revenue | US$24,754 |
Monthly Ads Revenue | US$742,605 |
Yearly Ads Revenue | US$8,911,255 |
Daily Unique Visitors | 206,280 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
avadel.com. | A | 3599 | IP: 99.84.216.101 |
avadel.com. | NS | 3600 | NS Record: ns70.domaincontrol.com. |
avadel.com. | NS | 3600 | NS Record: ns69.domaincontrol.com. |
avadel.com. | MX | 600 | MX Record: 10 primary.us.email.fireeyecloud.com. |
avadel.com. | MX | 600 | MX Record: 20 alt1.us.email.fireeyecloud.com. |
avadel.com. | MX | 600 | MX Record: 30 alt2.us.email.fireeyecloud.com. |
avadel.com. | MX | 600 | MX Record: 40 alt3.us.email.fireeyecloud.com. |
avadel.com. | MX | 600 | MX Record: 50 mx.us.email.fireeyecloud.com. |
avadel.com. | TXT | 600 | TXT Record: F0L1A15332 |
avadel.com. | TXT | 600 | TXT Record: logmein-verification-code=39f38d49-d862-461b-98d4-89713cf63f37 |
avadel.com. | TXT | 600 | TXT Record: v=spf1 include:spf.protection.outlook.com a:smtp-relay.avadel.com include:spf.mandrillapp.com -all |
avadel.com. | TXT | 600 | TXT Record: logmein-verification-code=ee4a6f9e-d5fd-4987-aba1-e92a44128df1 |
avadel.com. | TXT | 600 | TXT Record: MS=ms43261273 |
avadel.com. | TXT | 600 | TXT Record: adobe-idp-site-verification=762075b965a71fc59b5f61a7048325df6a1207090b1bd889b9307018df5320eb |
avadel.com. | TXT | 600 | TXT Record: apple-domain-verification=lCsmmxLecusMF2zG |
avadel.com. | TXT | 600 | TXT Record: docusign=bffbbfc2-20d9-4de1-b7ab-0dfa515748a5 |
avadel.com. | TXT | 600 | TXT Record: pardot_153951=e92d9ac9fa5569fa847fa1e626f1d32f8a5c4223dc54c8c97c8157ace92648a2 |
Recent News Investors Contact Us --> Menu Home About Us Our Focus Culture & Careers Recent News Investors Contact Us Stay up to date --> Transforming medicines to transform lives Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. About us Not an actual patient LUMRYZ is now approved by the FDA as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Learn more about our product Click here for full Prescribing Information, including BOXED WARNING , and Medication Guide. Important Safety Information WARNING: CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION AND ABUSE AND MISUSE Central Nervous System Depression LUMRYZ (sodium oxybate) is a CNS depressant. Clinically significant respiratory depression and obtundation may occur in patients treated with LUMRYZ at recommended doses. Many patients who received LUMRYZ during clinical trials in narcolepsy were receiving CNS |
HTTP/1.1 301 Moved Permanently Server: CloudFront Date: Wed, 27 Oct 2021 16:40:26 GMT Content-Type: text/html Content-Length: 183 Connection: keep-alive Location: https://avadel.com/ X-Cache: Redirect from cloudfront Via: 1.1 f8d44a9ae8d015e27eeaa90810b99a87.cloudfront.net (CloudFront) X-Amz-Cf-Pop: IAD79-C1 X-Amz-Cf-Id: De8_eRrdZCT2LRGOu-Eq2AtUTq5laTzYWno2KEPPzNZ0bssHq3DKCQ== HTTP/2 200 content-type: text/html content-length: 21224 x-amz-id-2: 8JWqrTAuyR59hhgflmLkyRwA//IszYUib/i9Eq+mKVd3Z1hUnqlmrVlZiXjDTpfhA4fS61Ys2rc= x-amz-request-id: DNEG49GC8S84ETQS last-modified: Fri, 15 Oct 2021 22:10:26 GMT accept-ranges: bytes server: AmazonS3 date: Wed, 27 Oct 2021 16:40:28 GMT etag: "e313265985145fbd7586e7237965c332" vary: Accept-Encoding x-cache: RefreshHit from cloudfront via: 1.1 bad43b7a5f64a218c0ba43b47a8d182f.cloudfront.net (CloudFront) x-amz-cf-pop: IAD79-C1 x-amz-cf-id: n6qepth_EMBS_kMUtjxybzEF-kygl_UstIW-YYdA0YeXxY33qGRmKQ== |
Domain Name: AVADEL.COM Registry Domain ID: 142007935_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2020-02-15T16:21:47Z Creation Date: 2005-02-10T01:28:32Z Registry Expiry Date: 2022-02-10T01:28:32Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS69.DOMAINCONTROL.COM Name Server: NS70.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T12:59:42Z <<< |